HIV Infections

Showing NaN - NaN of 408

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))

Not yet recruiting
  • HIV Infections
  • VH3810109
  • +3 more
  • Birmingham, Alabama
  • +42 more
Aug 9, 2023

Study of Multidrug-Resistant Patient Outcomes With and Without

Recruiting
  • HIV Infections
  • Multi-Antiviral Resistance
  • No ibalizumab or Pre-ibalizumab treatment
  • On ibalizumab treatment
  • Los Angeles, California
  • +38 more
Jan 31, 2023

Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

Recruiting
  • Hepatitis B
  • HIV Infections
  • San Diego, California
  • +35 more
Jan 31, 2023

HIV Trial in United States (PGT121.414.LS, VRC07-523LS)

Completed
  • HIV Infections
  • PGT121.414.LS
  • VRC07-523LS
  • Los Angeles, California
  • +4 more
Jan 31, 2023

HIV Trial in Canada, United States (CAB LA, RPV LA, RPV)

Active, not recruiting
  • HIV Infections
  • CAB LA
  • +3 more
  • Phoenix, Arizona
  • +29 more
Jan 22, 2023

HIV, HIV-1 Trial in Worldwide (Etravirine)

Active, not recruiting
  • HIV Infections
  • HIV-1
  • Los Angeles, California
  • +30 more
Jan 17, 2023

Consent for Use of Stored Patient Specimens for Future Testing

Recruiting
  • HIV Infections
    • Los Angeles, California
    • +62 more
    Dec 7, 2022

    HIV Trial in United States (APRETUDE, Cabotegravir OLI)

    Recruiting
    • HIV Infections
    • Los Angeles, California
    • +16 more
    Oct 24, 2022

    HIV, Sexually Transmitted Diseases Trial in San Francisco, Washington, Miami (PrEPmate, Dot Diary)

    Recruiting
    • HIV Infections
    • Sexually Transmitted Diseases
    • PrEPmate
    • Dot Diary
    • San Francisco, California
    • +3 more
    Sep 27, 2022

    HIV, Drug Use, Opioid Use Trial in United States (drug, diagnostic test, other, behavioral)

    Enrolling by invitation
    • HIV Infections
    • +3 more
    • Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
    • +10 more
    • Los Angeles, California
    • +4 more
    Aug 30, 2022

    The Women's HIV SeroIncidence Study (ISIS)

    Completed
    • HIV Infections
      • Washington, District of Columbia
      • +8 more
      Aug 25, 2022

      Acquired Immune Deficiency Syndrome (AIDS), HIV Trial in Worldwide (ATV, DRV, Cobicistat)

      Recruiting
      • Acquired Immune Deficiency Syndrome (AIDS)
      • HIV Infections
      • Long Beach, California
      • +29 more
      Aug 18, 2022

      HIV Trial in Worldwide (PGDM1400LS (5mg/kg, IV), PGDM1400LS (20mg/kg, IV), PGDM1400LS (20mg/kg, SC))

      Recruiting
      • HIV Infections
      • PGDM1400LS (5mg/kg, IV)
      • +16 more
      • San Francisco, California
      • +13 more
      Aug 12, 2022

      Antiretroviral Drugs and Related Drugs During and After

      Completed
      • HIV Infections
      • Birmingham, Alabama
      • +61 more
      Jun 28, 2022

      HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))

      Completed
      • HIV Infections
      • DTG + 3TC
      • TAF based regimen (TBR)
      • Phoenix, Arizona
      • +132 more
      Jun 27, 2022

      Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir (DTG), Lamivudine (3TC), Tenofovir disoproxil

      Active, not recruiting
      • Infection, Human Immunodeficiency Virus
      • HIV Infections
      • Dolutegravir (DTG)
      • +2 more
      • Phoenix, Arizona
      • +89 more
      Jun 27, 2022

      HIV Trial in Worldwide (GSK3640254, Dolutegravir, Lamivudine capsules)

      Active, not recruiting
      • HIV Infections
      • Bakersfield, California
      • +75 more
      Jul 1, 2022

      HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))

      Completed
      • HIV Infections
      • Placebo for maraviroc (MVC)
      • +3 more
      • Los Angeles, California
      • +29 more
      Apr 20, 2022

      Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)

      Completed
      • Infection, Human Immunodeficiency Virus
      • HIV Infections
      • Birmingham, Alabama
      • +180 more
      Mar 14, 2022

      HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)

      Recruiting
      • HIV Infections
      • Doravirine 100 Mg
      • +5 more
      • Birmingham, Alabama
      • +22 more
      Feb 22, 2022

      HIV Trial in Washington (HST-NEETs)

      Active, not recruiting
      • HIV Infections
      • HST-NEETs
      • Washington, District of Columbia
      • +2 more
      Feb 22, 2022

      HIV Trial in Worldwide (VRC01, Placebo for VRC01)

      Completed
      • HIV Infections
      • VRC01
      • Placebo for VRC01
      • Birmingham, Alabama
      • +25 more
      Feb 8, 2022

      Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir/abacavir/lamivudine FDC, Atazanavir, Ritonavir)

      Active, not recruiting
      • Infection, Human Immunodeficiency Virus
      • HIV Infections
      • Dolutegravir/abacavir/lamivudine FDC
      • +3 more
      • Phoenix, Arizona
      • +88 more
      Feb 8, 2022

      HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

      Active, not recruiting
      • HIV Infections
      • Birmingham, Alabama
      • +13 more
      Jan 13, 2022

      HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

      Active, not recruiting
      • HIV Infections
      • DTG 50 mg
      • +2 more
      • Long Beach, California
      • +64 more
      Dec 3, 2021